AU market earnings: Ingham's profit soars 68% as Telix Pharmaceuticals reverses loss
Ingham's profit rises 68% to $101.5 million, Telix Pharmaceuticals reports $29.7 million profit, reversing a loss, while Accent Group's profit falls 33%, plans asset sales and store expansions.
[AI generated]
This video was created on 23 August for IG audiences by ausbiz.
Ingham's profit soars, Telix reverses loss, and Accent faces decline
Ingham's profit rises 68% to $101.5 million, supported by revenue growth, but the company anticipates challenges in FY25 due to cost pressures. Telix Pharmaceuticals achieved a $29.7 million profit, reversing last year's loss, while Accent Group faced a 33% profit decline, planning to sell non-productive assets and expand store locations.
Centuria Capital reported a slight profit dip, focusing on capital management amid stable assets under management. Broker moves include Citi's raised target for Northern Star Resources and Morgans' upgrade of Megaport, despite lowering earnings forecasts.
This information has been prepared by IG, a trading name of IG Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.
CFDs are a leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your initial deposit, so please ensure that you fully understand the risks involved.
Explore the markets with our free course
Learn how shares work – and discover the wide range of markets you can trade on – with IG Academy's free ’introducing the financial markets’ course.
Put learning into action
Try out what you’ve learned in this shares strategy article risk-free in your demo account.
Ready to trade shares?
Put the lessons in this article to use in a live account – upgrading is quick and easy.
- Trade over 16,000 popular global stocks
- Protect your capital with risk management tools
- React to breaking news with out-of-hours trading on 70 key US stocks
Inspired to trade?
Put your new knowledge into practice. Log in to your account now.
Live prices on most popular markets
- Forex
- Shares
- Indices
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.
